Are Nitrosamines a Concern for Biologic Manufacturers

By SGS
Article

Sponsored Content

This article provides an assessment of nitrosamine contamination specifically in biologics and contrasts the potential risks between these product types.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Content
© 2025 MJH Life Sciences

All rights reserved.